Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...
As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results